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ABSTRACT Age of host and transplantation-site micro-
environment inf luence the tumorigenic potential of neoplas-
tically transformed liver epithelial cells. Tumorigenic BAG2-
GN6TF rat liver epithelial cells consistently form tumors at
ectopic sites, but differentially express tumorigenicity or
hepatocytic differentiation in the liver depending on host age
and route of cell transplantation into the liver. Direct inoc-
ulation into host livers concentrates tumor cells locally,
resulting in undifferentiated tumors near the transplantation
site in both young (3-month-old) and old (18-month-old) rats.
Transplantation-site tumors regress within 1 month in the
livers of young rats, but grow progressively in old rats.
However, inoculation of cells into the spleen distributes
transplanted cells individually throughout the liver, resulting
in hepatocytic differentiation by tumor cells with concomitant
suppression of their tumorigenicity in young rats. When
transplanted into livers of old rats by splenic inoculation, or
when young hepatic-transplant recipients are allowed to age,
hepatocytic progeny of BAG2-GN6TF cells proliferate to form
foci, suggesting that the liver microenvironment of old rats
incompletely regulates the proliferation and differentiation of
tumor cell-derived hepatocytes. Upon removal from the liver,
BAG2-GN6TF-derived hepatocytes revert to an undifferenti-
ated, aggressively tumorigenic phenotype. We posit that the
spectrum between normal differentiation and malignant po-
tential of these cells ref lects the dynamic interaction of the
specific transformation-related genotype of the cells and the
characteristics of the tissue microenvironment at the trans-
plantation site. Changes in the tissue milieu, such as those
that accompany normal aging, may determine the ability of a
genetically aberrant cell to produce a tumor.
Tumorigenesis is a complex molecular and cellular process that
culminates in the growth of aberrant cells in the context of a
specific tissue microenvironment in which the growth of
normal cells is tightly controlled. Target cells undergoing
neoplastic transformation incur multiple genetic aberrations
that enable them to grow autonomously in a regulative tissue
microenvironment. The role of age as a major risk factor for
the development of cancer (1, 2) has been hypothesized to
reflect the time required for a target cell to accumulate a
sufficient number and variety of genetic abnormalities to
enable it to grow autonomously (3, 4). Although genetic
malfunction is an essential feature of neoplastic cells, age-
dependent changes in the elements of the tissue microenvi-
ronment that are involved in regulating growth of parenchymal
cells may also have an important role in the increasing
frequency of cancer with advancing age (5, 6). We recently
have developed an experimental system with which to analyze
the interacting roles of cellular genotype and tissue microen-
vironment in the development of tumors, including age de-
pendency of tumor development (7, 8). This experimental
system employs the intrahepatic (i.h.) transplantation of ane-
uploid BAG2-GN6TF liver epithelial cells. These cells produce
tumors in 100% of neonatal rat hosts (9) and a high percentage
of adult hosts (8) with short latency when transplanted to s.c.
or i.p. sites. Our previous studies have shown that in young rats
i.h. transplants of BAG2-GN6TF cells, which deposit the
aneuploid cells in one location in the liver, rapidly produce
small tumors at the site of inoculation. However, these tumors
regress within 1 month of their formation (8). In contrast,
when BAG2-GN6TF cells are transplanted i.h. into old rats
they quickly produce expanding liver tumors that kill the host
rat (7). These results appear to support the hypothesis that
elements of the liver microenvironment can regulate the
proliferation and differentiation of genetically aberrant pa-
renchymal cells, that aneuploid tumorigenic cells may be
normalized by epigenetic influences, and that the regulatory
potency of the liver microenvironment declines with advancing
age.
In the present study we examine the epigenetic influences of
microenvironments on the phenotypic plasticity of BAG2-
GN6TF cells when the cells are subjected to different micro-
environments (liver and nonhepatic sites) in young and old
animals, as well as the stability of the differentiated phenotype
when cells are recovered from the liver and transplanted s.c. or
i.p. Our results show that the microenvironment of the liver
induces BAG2-GN6TF cells to adopt morphologic and func-
tional features of hepatocytic differentiation. When trans-
planted to extrahepatic tissue sites the cells are aggressively
tumorigenic and form undifferentiated tumors. Maintenance
of hepatocytic differentiation and suppression of tumorigenic
potential in BAG2-GN6TF cells requires sustained epigenetic
(microenvironmental) stimuli. Furthermore, age-associated
changes in the liver microenvironment result in the abnormal
proliferation of the hepatocytic progeny of transplanted
BAG2-GN6TF cells. When the differentiated hepatocyte-like
progeny of transplanted BAG2-GN6TF cells are recovered
from the regulatory (suppressive) liver microenvironment,
they revert to an undifferentiated neoplastic phenotype. This
study indicates that elements of the liver microenvironment
profoundly affect the phenotype expressed by genetically
aberrant liver epithelial cells and that alterations in the tissue
milieu, such as those that accompany advancing age, modify
the capacity of the liver microenvironment to regulate the
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked ‘‘advertisement’’ in
accordance with 18 U.S.C. §1734 solely to indicate this fact.
© 1998 by The National Academy of Sciences 0027-8424y98y9515333-6$2.00y0
PNAS is available online at www.pnas.org.
Abbreviations: b-gal, b-galactosidase; CFE, colony-forming effi-
ciency; DPPIV, dipeptidyl peptidase IV; HCC, hepatocellular carci-
noma; i.h., intrahepatic; NeoR, neomycin resistance gene; H&E,
hematoxylinyeosin.
*Present address: Gene Expression and Aging Section, Laboratory of
Biological Chemistry, Gerontology Research Center, National Insti-
tute on Aging, 4940 Eastern Avenue, Box 12, Baltimore, MD 21224.
†To whom reprint requests should be addressed at: Department of
Pathology and Laboratory Medicine, CB 7525, Room 414 BBB,
University of North Carolina School of Medicine, Chapel Hill, NC
27599. e-mail: cellsort@med.unc.edu.
15333
differentiation and tumorigenic potential of neoplastically
transformed liver epithelial cells.
MATERIALS AND METHODS
Cell Lines and Cell Transplantations. BAG2-WB and
BAG2-GN6TF cells have been described previously (9). Cell
transplant recipients consisted of age-controlled virgin male
Fischer 344 rats at 3 months (young rats) and 18 months (old
rats) of age (obtained from the Aged Rat Colony of the
National Institute on Aging, Harlan–Sprague–Dawley), and
German-strain Fischer 344 rats, which are deficient for dipep-
tidyl peptidase IV (DPPIV), at 3 months of age (generously
provided by Sanjeev Gupta, Marion Bessin Liver Research
Center, Albert Einstein College of Medicine, New York). All
animal studies were carried out in accordance with guidelines
put forth by the National Institutes of Health and the Insti-
tutional Animal Care and Use Committee of the University of
North Carolina.
BAG2-GN6TF cells (5 3 106 cellsy0.2 ml in physiological
saline) were transplanted into host rats by direct injection into
the median lobe of the liver (7–9) or by injection into the dorsal
tip of the spleen (9). Animals were euthanized 7, 14, 28, or 85
days after transplantation. One group of 3-month-old rats that
received BAG2-GN6TF cells was examined 14 months after
transplantation. Age-matched controls consisted of rats that
were not surgically manipulated or that received transplants of
the parental nontransformed BAG2-WB cells.
Enzyme Histochemistry and Immunohistochemistry. For-
malin-fixed liver and tumor tissues were processed and hema-
toxylinyeosin (H&E)-stained paraffin sections were prepared.
For analysis of b-galactosidase (b-gal) enzyme activity, tissue
was frozen in OCT freezing medium, liver cryosections (10-mm
thick) were prepared, and sections were incubated in an
5-bromo-4-chloro-3-indolyl b-D-galactoside-containing sub-
strate (8, 9). DPPIV enzyme activity was detected as described
(10, 11). All staining reactions included control sections from
livers of DPPIV1 and DPPIV2 rats to ensure the specificity
and quality of the histochemical reaction. Control tissues were
obtained from unmanipulated American- and German-strain
Fischer 344 rats. Bile canalicular ATPase was detected as
described (12). Colocalization of DPPIV and bile canalicular
ATPase was accomplished by first performing the DPPIV
staining reaction, washing the reacted tissue sections in PBS,
and then immediately processing the tissue for ATPase activ-
ity. All tissue sections were counterstained with Mayers he-
matoxylin or methyl green.
Expression of albumin and transferrin were examined im-
munohistochemically in frozen sections that had been stained
to detect b-gal or DPPIV activity (9, 11). Rabbit anti-rat
albumin antibodies and rabbit anti-rat transferrin antibodies
(Cappel) were used at a 1:200 dilution. Horseradish peroxi-
dase-conjugated goat anti-rabbit IgG (Dako) served as the
secondary antibody. Sections were developed in a diamino-
benzidine substrate (Vector Laboratories).
Recovery of BAG2-GN6TF Cells from Livers of Transplant
Recipients. Livers of host rats that had received transplants of
BAG2-GN6TF cells 1, 4, or 14 months earlier were dissociated
by using standard collagenase perfusion techniques (13). Pri-
mary liver cells were plated onto plastic tissue culture dishes
and maintained in Richter’s improved minimal essential me-
dium (14). The medium was changed every 3 days until
colonies of epithelial cells became apparent (10–14 days).
Epithelial colonies displaying the characteristic morphology of
BAG2-GN6TF cells were isolated by using cloning rings and
expanded. The origin of the recovered cell lines was estab-
lished by evaluating the clonal cell lines for b-gal expression
and neomycin resistance (9). The ability of individual recov-
ered cell lines to resist the cytotoxic effects of neomycin was
determined by culturing cells in growth medium containing
400 mgyml G418 (GIBCOyBRL). Cell lines exhibiting viability
after 14 days in medium containing G418 were considered to
be neomycin-resistant.
Isolation of Genomic DNA and Neo-PCR Analysis. Ampli-
fication of the coding sequence of the neomycin resistance
(NeoR) gene by PCR was used to determine the presence of
BAG2-retroviral DNA within genomic DNA samples isolated
from the recovered BAG2-GN6TF cell lines or from paraffin-
embedded BAG2-GN6TF tumors. Genomic DNA was isolated
from cultured cells by using standard procedures and from
paraffin-embedded tissue samples by using the Puregene DNA
isolation kit, as described by the manufacturer (Gentra Sys-
tems). Neo-PCR was accomplished by using synthetic oligo-
nucleotide primers complementary to DNA sequences located
in the coding region of the NeoR gene (sense: 59-
CATCGCCATGGGTCACGACG; antisense: 59-GGGC-
GAAGTGCCGGGGCAGG). Thirty-five cycles of amplifica-
tion with the Thermus aquaticus polymerase were performed
by using 96°C for denaturation, 60°C for primer annealing, and
72°C for elongation. As a control, the actin gene was PCR-
amplified by using commercial primers (Research Genetics,
Huntsville, AL).
Phenotypic Characterization of Recovered BAG2-GN6TF
Cells. Saturation densities of recovered cell lines were deter-
mined in monolayer culture (15). Anchorage-independent
growth was assayed as described (16). Tumorigenicity assays
were performed as described previously (14). Pregnant Fischer
344 rats at 14 days of gestation were obtained from Charles
River Laboratories. Recovered BAG2-GN6TF cell lines were
transplanted to s.c. or i.p. sites of 1-day-old neonatal rats (at
1 3 106 cells per animal). Latency was recorded as the time
required for the formation of tumors 1 cm in diameter.
RESULTS
Direct Inoculation of BAG2-GN6TF Cells into the Liver.
Direct inoculation of BAG2-GN6TF tumor cells into the
hepatic parenchyma resulted in the formation of tumors at the
transplantation site in all animals (young and old), as we
reported previously (8). In the livers of 18-month-old rats the
tumors were large ('1 cm in diameter) and displayed an
undifferentiated morphology that was indistinguishable from
the undifferentiated spindle-cell tumors that form after the
transplantation of BAG2-GN6TF cells to extrahepatic (s.c.
and i.p.) tissue sites of young (3-month-old) or old (18-month-
old) rats (Fig. 1 A and B). Likewise, i.h. tumors developing in
young rats exhibited an undifferentiated morphology, but in
contrast to the i.h. tumors of old rats, tumors in young animals
regressed within 1 month (8). I.h. tumors resulting from direct
inoculation of BAG2-GN6TF cells into the liver weakly ex-
pressed albumin and transferrin and contained some cells that
were diffusely DPPIV1 (data not shown). Tumor cells that
weakly expressed these hepatocyte-specific proteins usually
were located near the tumoryparenchyma border, suggesting
that the adjacent normal parenchyma affected the phenotype
of the tumor cells.
Inoculation of BAG2-GN6TF Cells into the Spleen. Dis-
persal of BAG2-GN6TF cells throughout the hepatic paren-
chyma was accomplished by inoculating cells into the spleens
of host rats. Under these conditions no i.h. tumors formed in
young adult rats, but b-gal1 progeny of BAG2-GN6TF cells
were detected in all transplant recipients as single or as small
groups of hepatocyte-like cells (Table 1 and Fig. 2A). The
identity of tumor cell-derived hepatocyte progeny in livers of
host rats was confirmed by transplanting BAG2-GN6TF cells
into livers of DPPIV2 rats and assaying for DPPIV enzymatic
activity. When transplanted into livers of DPPIV2 rats by
splenic inoculation, DPPIV1 hepatocytic progeny of the trans-
planted BAG2-GN6TF cells were readily identified against a
background of DPPIV2 host hepatocytes (Fig. 2 B and C). The
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DPPIV1 hepatocytes in hepatic plates were comparable to
adjacent host hepatocytes in size and morphology. Close
physical contact between the differentiated progeny of the
transplanted tumor cells and host hepatocytes was demon-
strated by colocalization of DPPIV staining and bile canalic-
ular ATPase activity in hybrid bile canaliculi (Fig. 2 B and C).
Immunohistochemical stains showed that DPPIV1 hepato-
cyte-like BAG2-GN6TF cells expressed both albumin (Fig.
2C) and transferrin (data not shown). b-Gal1 hepatocytes also
expressed albumin or transferrin as demonstrated by immu-
nostaining (data not shown). BAG2-GN6TF-derived hepato-
cytes were identified in host rats at all time points examined
after transplantation, including the earliest time point exam-
ined (7 days after transplantation). Thus, tumor cells differ-
entiated rapidly after their introduction into the liver micro-
environment.
Effects of Age on BAG2-GN6TF Cells in the Liver. After
transplantation of BAG2-GN6TF cells into livers of 18-month-
old rats by inoculation into the spleen, single and small groups
of b-gal1 hepatocyte-like cells were identified in the hepatic
parenchyma of all transplant recipients. In addition, foci of
multiple hepatocyte-like BAG2-GN6TF progeny also were
observed in livers of old transplant recipients (Fig. 2D).
Hepatocyte progeny of BAG2-GN6TF cells proliferated to
form foci soon after their transplantation into the livers of old
rats, as evidenced by the presence of foci of b-gal1 hepatocyte-
like cells at early time points after transplantation (7 days after
transplantation). Livers of the majority of old transplant
recipients harbored b-gal1 hepatocyte foci 7 and 14 days after
transplantation and the foci were maintained in the livers of all
old rats at the later time points (Table 1). Because old DPPIV2
rats are not available, the formation of foci of BAG2-GN6TF
cells could only be assessed using the b-gal reporter enzyme.
Foci were composed of b-gal1 hepatocyte-like cells that were
organized into plates separated by sinusoidal spaces; however,
the plates were not smoothly continuous with the host hepatic
plates. In contrast to these results with transplanted BAG2-
GN6TF cells, b-gal1 hepatocyte foci were never seen in either
young or old rats after transplantation of normal BAG2-WB
cells (data not shown).
The fate of BAG2-GN6TF cells transplanted into the livers
of old rats via the spleen was difficult to determine because of
the formation of extrahepatic tumors, presumably from the
inadvertent introduction of tumor cells into the i.p. cavity
during transplantation. Among one group of 18-month-old
rats, five of five developed extrahepatic tumors and three of
five required early euthanasia. The range of survival times for
these groups of old rats was 35–85 days, and the mean time of
survival was 64 6 20 days. The liver of one of the two rats that
survived to the 85-day endpoint contained a large (.2-cm
diameter) well differentiated hepatocellular carcinoma (HCC;
Fig. 1D). This tumor weakly expressed b-gal (data not shown),
indicating its origin from the transplanted tumor cells. Neo-
PCR showed that the tumor cells contained the NeoR gene in
their genomic DNA (Fig. 3), verifying the origin of this tumor
from BAG2-GN6TF cells.
Injection-site tumors regressed from the livers of young rats
that were maintained for .28 days after cell transplantation
(8), enabling examination of the long-term fate of differenti-
ated progeny of the transplanted tumor cells. Single and small
groups of b-gal1 progeny of the transplanted cells were
identified in livers of all (five of five) transplant recipients 14
months after the transplantation of BAG2-GN6TF cells into
3-month-old rats, and multicellular foci of BAG2-GN6TF
progeny were present in four of five old rats in this group (Fig.
2D and Table 1). However, no neoplastic lesions were identi-
fied in any of these rats. The b-gal1 hepatocytes and foci
observed in this group of old rats expressed both albumin and
transferrin (data not shown).
Dedifferentiation of BAG2-GN6TF Progeny upon Removal
from Host Livers. Progeny of BAG2-GN6TF cells that resided
in livers of host rats for 1, 4, or 14 months as differentiated
hepatocytes were reestablished in cell culture from collage-
nase-dispersed primary liver cell preparations. In the primary
liver cell preparations from these animals, b-gal staining was
limited to morphologically identifiable hepatocytes (data not
shown). In addition to epithelial cell colonies with normal
morphology, which are readily established from normal rat
liver (13), colonies of irregularly shaped spindle cells were
established from primary liver cell preparations representing
each animal that received BAG2-GN6TF cell transplants.
Epithelial cell colonies established from the livers of unma-
nipulated control rats (no BAG2-GN6TF cell transplant) or
from the livers of rats that received transplants of untrans-
formed diploid BAG2-WB cells did not exhibit this aberrant
morphology. All of the recovered BAG2-GN6TF cell lines
isolated 1 and 4 months after cell transplantation expressed
neomycin resistance in cell culture, while those isolated 14
months after transplantation did not (Table 2). BAG2-GN6TF
clones isolated 1 and 4 months after transplantation expressed
strong or moderate levels of b-gal activity, while cell lines
reestablished from the livers of rats 14 months after trans-
plantation were weakly positive or, in some cases, negative
(Table 2 and Fig. 4). Neo-PCR verified the origin of these cell
lines. All recovered cell lines are positive for this genetic
marker of the transplanted cells (Table 2).
The cell lines established from livers of BAG2-GN6TF
transplant recipients exhibited a transformed morphology in
vitro that is indistinguishable from the morphology of the
parental BAG2-GN6TF cells (Fig. 4). Growth of the recovered
cell lines was not inhibited by cellular contact; while some cell
lines grew to saturation densities that were reduced relative to
BAG2-GN6TF cells, most were comparable to the BAG2-
GN6TF cell line (Table 2). All recovered cell lines are capable
of anchorage-independent growth, although the colony-
forming efficiency (CFE) of some of the lines in soft agar was
reduced relative to the parental BAG2-GN6TF cell line (Table
FIG. 1. Histology of BAG2-GN6TF tumors. (A) Undifferentiated
spindle-cell tumor that formed after transplantation of BAG2-GN6TF
cells to the s.c. site of an 18-month-old rat (harvested 85 days after cell
transplantation, H&E). (B) Undifferentiated spindle-cell tumor pro-
duced by direct injection of BAG2-GN6TF cells into the liver of an
18-month-old rat (harvested 28 days after cell transplantation, H&E).
(C) S.c. tumor formed after transplantation of BAG2-GN6TF cells
recovered from the liver of a host rat 14 months after transplantation
(H&E). (D) Well differentiated HCC that arose in an 18-month-old
rat 85 days after transplantation of BAG2-GN6TF cells into the liver
by injection of cells into the spleen (H&E).
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2). Length of residence in the liver as differentiated hepato-
cytes did not significantly alter the CFE of recovered progeny;
the average CFE of cell lines isolated 1 month after trans-
plantation was 7.7 6 2.0%, while the average CFE of cell lines
isolated 14 months after transplantation was 7.2 6 1.6%. All
recovered BAG2-GN6TF cell lines were 100% tumorigenic at
s.c. or i.p. transplantation sites of 1-day-old neonatal rats with
short latency (Table 2). Tumors that formed after transplan-
tation of the recovered cell lines contain undifferentiated
spindle cells, which are indistinguishable from tumors pro-
duced by the parental BAG2-GN6TF cells (Fig. 1).
DISCUSSION
Several previous studies have reported that some tumor cells
are induced to differentiate in vitro by incorporation of specific
chemical and biological agents into the culture medium and
that after removal of the differentiating stimulus the tumor
cells undergo phenotypic simplification or dedifferentiation
(17–20). In addition, studies have documented the participa-
tion of teratocarcinoma cells in normal mouse development
after their transplantation into the blastocyst (21–26) and
regulation of differentiation of other tumor cell types by
appropriate embryonic fields (27, 28). These studies suggested
that the phenotype expressed by transformed cells is dynamic
and subject to normalization in response to epigenetic (mi-
croenvironmental) regulation (26). However, examination of
the plasticity of the tumorigenic phenotype of transformed
epithelial cells after their transplantation into the microenvi-
ronment of an adult tissue in vivo has not been reported. We
report here that aneuploid tumorigenic rat liver epithelial cells
incorporate into host hepatic plates and differentiate morpho-
logically and functionally into hepatocytes after they are
transplanted into the liver (by inoculation into the spleen).
These same tumor cells express an abnormal phenotype when
the microenvironment of the liver is altered either by concen-
trating tumor cells locally within the liver parenchyma or by
natural aging of the liver microenvironment. Furthermore, the
hepatocyte-like progeny of BAG2-GN6TF cells revert to an
undifferentiated, tumorigenic phenotype immediately upon
recovery from the liver and reestablishment in culture. These
findings demonstrate retrodifferentiation of tumor cells that
had been induced to differentiate by transplantation into a
specific tissue microenvironment of the adult rat. Our data
indicate that some genetically aberrant cells can differentiate,
with concomitant suppression of their tumorigenicity, in re-
sponse to appropriate (adult) tissue microenvironments in
vivo, and that their differentiated progeny require constant,
tissue-specific epigenetic regulation to remain phenotypically
normal.
FIG. 2. Hepatocyte differentiation by BAG2-GN6TF cells trans-
planted to the liver by splenic inoculation. The differentiated progeny
of transplanted tumor cells were distinguished from host hepatocytes
in livers of syngeneic rats based on their expression of b-gal (blue
chromagen, A and D) or DPPIV (red chromagen, B and C). (A)
b-Gal1 hepatocyte progeny of BAG2-GN6TF cells in a 3-month-old
rat. (B) Colocalization of DPPIV enzyme activity and bile canalicular
ATPase activity (brown precipitate) in the liver of young-adult DP-
PIV2 rats containing DPPIV1 hepatocyte progeny of BAG2-GN6TF
cells. (C) Immunohistochemical detection of albumin (black precipi-
tate) in DPPIV1 hepatocyte progeny of BAG2-GN6TF cells in
3-month-old rat liver. (D) Foci of b-gal1 hepatocytes in the liver of an
18-month-old rat 14 days after transplantation of BAG2-GN6TF cells
to the liver by splenic inoculation. Identical foci of b-gal1 hepatocytes
were observed in the livers of rats 14 months after transplantation of
BAG2-GN6TF cells into the liver of a 3-month-old rat (data not
shown).
FIG. 3. PCR detection of the neomycin-resistance gene in BAG2-
GN6TF-derived HCC. Identical DNA templates were used in the PCR
amplification of the NeoR gene and the actin gene. Lanes marked M
contain molecular size markers (100-bp ladder). Lanes: 1, no DNA
control; 2, DNA template from BAG2-GN6TF cells; 3, pSV2neo
plasmid DNA (positive control for NeoR gene); 4, DNA template from
paraffin-embedded control rat liver; 5, DNA template from paraffin-
embedded HCC (from Fig. 1D).
Table 1. Frequency of hepatocytic differentiation (single cells), hepatocyte focus formation, and liver tumor development by BAG2-GN6TF
cells after transplantation into the livers of syngeneic hosts by injection into the spleen
Time*, days
Young adult rats (3 months old) Old rats (18 months old)
Single cells Hepatocyte foci† Liver tumors Single cells Hepatocyte foci† Liver tumors
7 3y3 0y3 0y3 5y5 4y5 0y5
14 3y3 0y3 0y3 6y6 4y6 0y6
21 3y3 0y3 0y3 3y3 3y3 0y3
28 3y3 0y3 0y3 3y3 3y3 0y3
85 3y3 0y3 0y3 5y5 5y5 1y5‡
440§ 5y5 4y5 0y5 ND ND ND
ND, not determined.
*Days after transplantation.
†Clusters of b-gal1 hepatocytes organized into plates separated by sinusoidal spaces.
‡Two animals survived to the 85-day end point. The liver of one rat contained a well differentiated HCC (see Figure 1D).
§Three-month-old rats that received cell transplants by spleen injection were allowed to age naturally for 14 months before determination of the
fate of the transplanted tumor cells.
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Consistent with our previous report (8), direct inoculation of
a bolus of BAG2-GN6TF tumor cells into the hepatic paren-
chyma of rats is followed by formation of i.h. tumors. These
data sharply contrast with those obtained when the tumor cells
are transplanted into the liver via the spleen, which distributes
transplanted cells throughout the liver as single cells and which
does not result in the rapid development of hepatic tumors in
either young or old rats (Table 1). The different outcomes
produced by these two transplantation methods most likely
reflect differences in the local tissue microenvironment en-
countered by the transplanted tumor cells in the liver. Inclu-
sion of tumor cells in a group of similar abnormal cells is
associated with their heightened production of and response to
autocrine and paracrine growth factors (29, 30). Thus, tumor
cells that are concentrated at the site of injection by direct
inoculation into the liver may encounter local concentrations
of cytokines and growth factors that are not characteristic of
the normal liver. Perhaps more important, tumor cells inoc-
ulated into the liver as a bolus lack close physical contact with
parenchymal cells and other elements of the normal hepatic
extracellular matrix that may be necessary for suppression of
the neoplastic phenotype of the transplanted tumor cells.
Dispersal of tumor cells throughout the hepatic parenchyma
(achieved by splenic inoculation) facilitates interaction be-
tween the transplanted cells and differentiation-promoting
factors in the hepatic microenvironment. Intimate contact
between the transplanted BAG2-GN6TF tumor cells and
elements in the normal hepatic microenvironment appears to
be essential for induction and maintenance of differentiation
and suppression of tumorigenicity.
Data obtained from the transplantation of rat liver epithelial
tumor cells into livers of old rats (via injection into the spleen)
support our previous suggestion that the regulatory capacity of
the liver microenvironment declines as rats age (7, 8). Al-
though transplanted tumor cells respond to the epigenetic,
differentiation-promoting signals present in the hepatic mi-
croenvironment of old rats, the hepatocyte progeny of the
transplanted tumor cells continue to proliferate in the livers of
old rats and generate foci of differentiated hepatocyte-like
cells. Foci of tumor cell progeny are present in livers of old rats
as early as 7 days after transplantation, indicating that hepa-
tocyte progeny of BAG2-GN6TF cells proliferate soon after
their introduction into livers of old rats. It is unlikely that the
foci represent BAG2-GN6TF cells that incorporated into host
hepatic plates as large groups of cells because (i) untrans-
formed BAG2-WB cells do not form such foci after their
transplantation into livers of old rats and (ii) BAG2-GN6TF
cells do not generate hepatocyte foci when they are trans-
planted into the livers of young rats. These observations
suggest that although the liver microenvironment of old rats
can regulate (at least in part) the differentiation of trans-
planted tumor cells, it is unable to suppress the proliferation
of these apparently differentiated cells. Foci of hepatocyte
progeny of BAG2-GN6TF cells may represent pretumorigenic
lesions that, given enough time, will generate hepatic tumors.
In the current study, most of the old rats that received tumor
cell transplants did not survive long enough for tumors to
develop in the liver, because of the occurrence of extrahepatic
tumors. Thus, although the ability of tumor cells to form
tumors in the livers of old rats after inoculation into the spleen
was not conclusively determined, the finding of a well differ-
entiated HCC in one of these old rats that survived 85 days
after transplantation suggests that progeny of BAG2-GN6TF
FIG. 4. Expression of b-gal enzyme activity in BAG2-GN6TF cell lines. (A) Parental BAG2-GN6TF cells. (B) A representative clonal cell line
established from a primary liver cell dispersion prepared 1 month after transplantation of BAG2-GN6TF cells. (C) Representative clonal cell line
established from a primary liver cell dispersion prepared 14 months after transplantation of BAG2-GN6TF cells (weak b-gal expression).
















BAG2-GN6TF 1 1 1 16 6 2 2.8 3 105 100 (20y20) 21 6 4
R1.1 1 1 1 8.9 6 1.4 2.2 3 105 100 (10y10) 27 6 2
R1.2 1 1 1 6.0 6 0.9 2.0 3 105 100 (4y4) 34 6 2
R1.3 1y2* 1 1 10.0 6 1.3 1.8 3 105 100 (10y10) 32 6 2
R1.4 1 1 1 6.0 6 0.9 2.0 3 105 100 (7y7) 39 6 1
R14.1 1 2 1 3.3 6 0.4 1.4 3 105 100 (5y5) 31 6 2
R14.2 2 2 1 4.8 6 0.3 2.0 3 105 100 (6y6) 39 6 1
R14.3 1y2 2 1 5.3 6 0.5 6.7 3 105 100 (9y9) 27 6 1
R14.4 2 2 1 11.3 6 0.5 2.9 3 105 100 (5y5) 22 6 1
R14.5 1y2 2 1 5.8 6 0.5 2.8 3 105 100 (8y8) 29 6 1
R14.6 1 2 1 12.6 6 0.9 3.3 3 105 100 (5y5) 28 6 1
All rats were 3 months old at the time of cell transplant. R1 and R14 cell lines were established from the livers of rats 1 month (n 5 2 rats)
or 14 months (n 5 3 rats) after transplantation of BAG2-GN6TF cells. NeoR expression is expression of antibiotic resistance by cells cultured in
the presence of G418. NeoR PCR is detection of the BAG2 retroviral Tn5 neomycin resistance gene by PCR amplification. Column labeled
Tumorigencity shows the percentage of animals forming tumors after transplantation to s.c. or i.p. sites of 1-day-old syngeneic rats (tumors
formedyanimals injected). Tumor latency is the average time to formation of a tumor of 1-cm diameter.
*Moderate levels of b-gal activity expressed.
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cells that form foci continue to proliferate in the liver of old
rats and eventually progress to form tumors.
When young rats with single or small groups of hepatocyte
progeny of BAG2-GN6TF cells in their livers were allowed to
age for 14 months, foci of b-gal1 hepatocyte-like cells devel-
oped. This observation is important for several reasons. First,
it demonstrates that genetically aberrant (but phenotypically
normal) cells are capable of long-term survival in the liver.
Second, it provides additional support for our hypothesis that
the regulatory capacity of the liver declines with age. Third, it
shows that when the regulatory capacity of the liver microen-
vironment declines, hepatocytic progeny of BAG2-GN6TF can
reenter the cell cycle and proliferate. The absence of foci of
BAG2-GN6TF-derived hepatocyte-like cells in the livers of
young rats indicates that the proliferation of these cells is
suppressed in young livers. It is not until the animal (and, more
specifically, the hepatic microenvironment) ages that these
quiescent cells acquire the potential to proliferate abnormally.
The results of the present study suggest that the hepatocytic
progeny of BAG2-GN6TF cells in livers of young rats could
give rise to hepatic tumors in hosts that are allowed to attain
naturally an advanced age (18–24 months old).
Collagenase dissociation of the livers of BAG2-GN6TF
transplant recipients yields isolated epithelial cells that in
culture form colonies of cells that have the characteristic
morphology of BAG2-GN6TF tumor cells. The recovered
BAG2-GN6TF cell lines display multiple phenotypic charac-
teristics in vitro that are indistinguishable from those of the
parental tumor cell line, and they are highly tumorigenic after
s.c. or i.p. transplantation into syngeneic hosts. We have
established numerous epithelial cell lines from normal rat
livers (13), but these cell lines have never expressed transfor-
mation-related phenotypes in vitro or tumorigenic potential in
vivo (unpublished observation). Furthermore, recovery from
the liver of hepatocyte-like progeny of transplanted
BAG2-WB cells yields nontumorigenic cells that are nearly
identical to the cells originally transplanted (13). Our finding
that BAG2-GN6TF cells differentiate into hepatocyte-like
cells in the liver but revert to an undifferentiated, tumorigenic
phenotype upon removal from the liver, combined with the
observation that the hepatocyte progeny of transplanted
BAG2-GN6TF cells proliferate abnormally in livers of old rats,
indicates strongly that the tissue microenvironment has a
determining role in mediating the phenotype expressed by
these genetically aberrant cells. While genomic alterations
undoubtedly play a critical role in neoplastic transformation,
disruption of normal homeostatic relations between trans-
formed cells and their tissue microenvironment appears to be
equally relevant to tumor formation (6, 31). Since the pheno-
type expressed by transformed cells is dynamic and potentially
regulatable, extracellular forces represent essential determi-
nants of the malignant behavior of a transformed cell.
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